Oxcarbazepine Tablet, Film Coated
Product Images NDC 72888-087

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 72888-087). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advagen Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Oxcarbazepine Tablets, Usp (150mg)

Label for Oxcarbazepine Tablets USP 150 mg film-coated tablets by Advagen Pharma Limited. The label states the package contains 100 tablets for oral use and includes storage instructions, manufacturer and distributor information, a medication guide website, and pharmacist directions to provide the guide to patients.*

FDA Label Image

Oxcarbazepine Tablets, Usp (150mg)

Label for Oxcarbazepine Tablets USP 150 mg, film-coated oral tablets. The package contains 30 tablets. Distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited. The label includes storage instructions, a barcode, and dosage guidance references.*

FDA Label Image

Oxcarbazepine Tablets, Usp (150mg)

Label for Oxcarbazepine Tablets, USP 150 mg, film-coated oral tablets. The label shows a package size of 500 tablets and states Rx Only. It includes storage instructions, a pharmacist advisory to dispense the medication guide, distribution by Advagen Pharma Limited, and manufacturing by Rubicon Research Private Limited, India. The label features an NDC code and has dosage and safety warnings.*

FDA Label Image

Oxcarbazepine Tablets, Usp (300mg)

Label for Oxcarbazepine Tablets, USP 300 mg film-coated tablets, 100 count. The label includes storage instructions, dispensing warnings, and pharmacist guidance. Distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited. The label also provides an NDC code, barcode, and directs to a medication guide online.*

FDA Label Image

Oxcarbazepine Tablets, Usp (300mg)

Label for Oxcarbazepine Tablets USP 300 mg, film-coated tablets in a package of 30 tablets. The label includes storage instructions, dosage form, labeler Advagen Pharma Limited, and manufacturer Rubicon Research Private Limited. It also features an NDC number 72888-088-30 and mentions the availability of a medication guide.*

FDA Label Image

Oxcarbazepine Tablets, Usp (300mg)

Label for Oxcarbazepine Tablets, USP 300 mg, film-coated oral tablets. The label indicates a quantity of 500 tablets and is marked Rx Only. Distributed by Advagen Pharma Limited, Plainsboro, NJ, and manufactured by Rubicon Research Private Limited, India. Storage instructions and caution to keep out of reach of children are included.*

FDA Label Image

Oxcarbazepine Tablets, Usp (600mg)

Oxcarbazepine Tablets, USP 600 mg film-coated tablets in a bottle of 100 count. The label includes storage instructions, medication guide availability, distributor Advagen Pharma Limited, and manufacturer Rubicon Research Private Limited. This is an oral prescription drug.*

FDA Label Image

Oxcarbazepine Tablets, Usp (600mg)

Label for Oxcarbazepine Tablets USP, 600 mg, film-coated oral tablets supplied in a 30-tablet package. The label includes storage instructions, NDC 72888-089-30, distributor Advagen Pharma Limited, and manufacturer Rubicon Research Private Limited, India. It also references a medication guide and pharmacist dispensing instructions.*

FDA Label Image

Oxcarbazepine Tablets, Usp (600mg)

Label for Oxcarbazepine Tablets USP 600 mg film-coated tablets, packaged in a quantity of 500. The label includes storage instructions, dosage warnings, and pharmacist dispensing guidance. Distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited, India. Features barcode, NDC 72888-089-05, and website for medication guide.*

FDA Label Image

Figure 1 Kaplan-meier Estimates Of Exit Rate By Treatment Group. (Oxcarbazepine Tabs Usp Fig1)

A Kaplan-Meier survival curve chart showing the exit rate over time in days from Day 2 comparing two treatment groups: oxcarbazepine and placebo. The x-axis represents time in days, and the y-axis represents the exit rate fraction. The chart includes a log-rank test with a p-value of 0.0001, indicating statistical comparison between the two groups.*

FDA Label Image

Figure 2 Kaplan-meier Estimates Of First Seizure Event Rate By Treatment Group. (Oxcarbazepine Tabs Usp Fig2)

A Kaplan-Meier survival curve comparing seizure rates over time between treatment groups receiving Oxcarbazepine and placebo. The x-axis represents days from first dose to first seizure, while the y-axis shows the seizure rate. The graph includes a statistical note of a log-rank test with p-value 0.046 indicating a comparison between the groups.*

FDA Label Image

Figure 3 Kaplan-meier Estimates Of Exit Rate By Treatment Group. (Oxcarbazepine Tabs Usp Fig3)

A Kaplan-Meier survival plot showing time to exit in days for two treatment groups labeled HIGH and LOW. The x-axis represents time to exit in days from 0 to 130, and the y-axis represents the exit rate from 0.0 to 1.0. The HIGH group is depicted by a solid line, and the LOW group by a dotted line. A log-rank test with p-value 0.0001 is noted on the chart.*

FDA Label Image

Figure 4 Kaplan-meier Estimates Of Exit Rate By Treatment Group. (Oxcarbazepine Tabs Usp Fig4)

A Kaplan-Meier survival curve chart comparing two treatment groups labeled HIGH and LOW. The x-axis represents time to exit in days (0 to 130), and the y-axis represents exit rate (0 to 1). The chart includes a log-rank test p-value of 0.0001, indicating statistical comparison between groups.*

FDA Label Image

Oxcarbazepine Structural Formula. (Oxcarbazepine Tabs Usp Structural Formula)

Chemical structure of oxcarbazepine, showing its molecular arrangement including ketone, amide, and aromatic ring components as relevant to the active ingredient in the product Oxcarbazepine.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.